Status:
COMPLETED
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
Lead Sponsor:
Abbott Products
Conditions:
Recurrent Miscarriage
Eligibility:
FEMALE
18-38 years
Phase:
PHASE3
Brief Summary
The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphasto...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Women with a history of idiopathic recurrent miscarriage, based on a documented history of at least three spontaneous consecutive miscarriages before 20 weeks gestation with the same partner Exclusion Criteria
- Any verifiable cause of the recurrent miscarriages apart from luteal phase defect (e.g. systemic lupus erythematosus \[SLE\], infections with chlamydia or mycoplasma)
- Any gynecological neoplasias or anatomical abnormalities that oppose pregnancy
- Concurrent infertility treatment/superovulation protocol
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00193674
Start Date
September 1 2003
End Date
July 1 2009
Last Update
August 26 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 61182
Vienna, Austria, 1090
2
Site Reference ID/Investigator# 61183
Poznan, Poland, 60-535
3
Site Reference ID/Investigator# 61184
Szczecin, Poland, 72-010